| CHEMICAL INDUSTRY JOURNAL |
| green chemicals |
HydRegen’s proprietary enzyme platform implemented into sustainable chemical processes Bioscience company HydRegen focuses on sustainable chemical manufacturing using their proprietary enzyme based redox platform. The company has received £385,000 in new funding from the UK Innovation & Science Seed Fund (UKI2S), alongside private investors, to work in collaboration with pharmaceutical and fine chemical companies that want to reduce their costs and environmental impact.
new chemical processes. HydRegen will work alongside UK-based pharmaceutical and chemical company Almac Sciences, part of the Almac Group, to evaluate a joint technology development project for large-scale manufacture of a commodity chemical.
Development of greener and less wasteful processes is at the forefront for many companies who are under increasing regulatory, policy and financial pressures to improve their sustainability. HydRegen is addressing unmet needs in the chemical sector, most specifically around the challenges associated with redox reactions*, their waste generation and use of toxic metals.
The project will use enzyme technologies from both companies in a multi-enzyme system to develop a low-cost manufacturing process, producing cost effective green alternatives to commodities.
The newly raised funds will enable HydRegen to invest in the people and resources required to develop and scale up its platform and subsequent implementation into
Since spinning out from the University of Oxford in 2021, HydRegen has focused on implementation of their new strategies for reducing the environmental impact of active pharmaceutical ingredient (API) manufacturing, by switching the power source for biocatalysis from glucose to hydrogen gas. With a vision to replace finite resources,
40
